当前位置: 制药设备 >> 制药设备前景 >> 中文WHO制药用水2021TRS103
WHOTRS第55次报告Annex3Goodmanufacturingpractices:waterforpharmaceuticaluse优良生产规范(GMP):制药用水
Background背景
Unlikeotherproductorprocessingredients,waterisusuallydrawnfromanondemandsystemandisnotsubjecttotestingandbatchorlotreleasepriortouse.Thusitisessentialthatwaterquality(includingmicrobiologicalandchemicalquality)throughoutproduction,storageanddistributionprocessesiscontrolled.
与其他产品或工艺成分不同,水通常是从按需制备的系统提取,且在使用前不受检测和批放行限制。因此,对从生产、储存和分配全过程中的水质(包括微生物和化学质量)进行控制是至关重要的。
Inrecentyears,followingextensiveconsultationswithstakeholders,severalpharmacopoeiashaveadoptedrevisedmonographsonwaterforinjection(WFI)thatallowforproductionbynon-distillationtechnologies.In,theWorldHealthOrganization(WHO)ExpertCommitteeonSpecificationsforPharmaceuticalPreparations(ECSPP)re
转载请注明:http://www.aideyishus.com/lkcf/2385.html